Moreover, PR-957 markedly improved Ang II–induced cardiac contractile dysfunction as reflected by EF%, and reduced cardiac hypertrophy as indicated by decreases in heart size, HW/BW and HW/TL ratios, cross-sectional area of myocytes and ANF expression (Figures 5B–E). Here, AGT is linked to cardiac hypertrophy.